Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.16M | $0.80 | $32.67 | 3,988.49% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $16.25M | $0.39 | $13.00 | 3,250.52% | Strong Buy | 2 | N/A | N/A | -4,247.85% | -262.68% | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $2.16M | $1.79 | $45.00 | 2,413.97% | Strong Buy | 2 | N/A | N/A | N/A | -503.12% | |||
| IMA | IMAGENEBIO INC | $35.35M | $8.79 | $153.00 | 1,640.61% | Buy | 2 | N/A | N/A | -21.45% | -19.70% | |||
| ACXP | ACURX PHARMACEUTICALS INC | $9.00M | $5.68 | $95.50 | 1,581.34% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| PSTV | PLUS THERAPEUTICS INC | $53.60M | $0.54 | $8.00 | 1,381.48% | Strong Buy | 4 | 55.12% | N/A | -100.12% | -29.35% | |||
| MRSN | MERSANA THERAPEUTICS INC | $47.71M | $9.56 | $140.00 | 1,364.44% | Strong Buy | 2 | -29.73% | N/A | N/A | -29.19% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $174.99M | $0.58 | $8.33 | 1,336.72% | Strong Buy | 3 | 9.48% | N/A | 240.73% | 48.37% | |||
| ATYR | ATYR PHARMA INC | $86.25M | $0.97 | $13.63 | 1,306.09% | Buy | 4 | N/A | N/A | -38.51% | -29.72% | |||
| FGEN | FIBROGEN INC | $44.12M | $10.91 | $146.50 | 1,242.80% | Buy | 2 | N/A | N/A | N/A | -19.48% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $30.13M | $2.07 | $26.67 | 1,188.26% | Buy | 3 | 273.21% | N/A | N/A | -57.00% | |||
| GRI | GRI BIO INC | $4.45M | $1.77 | $22.50 | 1,171.19% | Buy | 2 | N/A | N/A | -26.77% | -15.67% | |||
| NRXP | NRX PHARMACEUTICALS INC | $60.10M | $3.05 | $37.00 | 1,113.11% | Strong Buy | 2 | N/A | N/A | -282.17% | 2,077.22% | |||
| TVRD | TVARDI THERAPEUTICS INC | $44.82M | $4.78 | $55.50 | 1,061.09% | Strong Buy | 6 | -87.30% | N/A | -101.00% | -76.02% | |||
| FEMY | FEMASYS INC | $17.13M | $0.63 | $7.00 | 1,012.88% | Strong Buy | 2 | 154.02% | N/A | -125.24% | -18.83% | |||
| CING | CINGULATE INC | $19.27M | $3.56 | $39.50 | 1,009.55% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| MDCX | MEDICUS PHARMA LTD | $40.98M | $2.30 | $23.50 | 921.74% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| SKYE | SKYE BIOSCIENCE INC | $48.96M | $1.58 | $15.00 | 849.37% | Buy | 3 | N/A | N/A | -163.55% | -136.95% | |||
| NOTE | FISCALNOTE HOLDINGS INC | $57.40M | $4.00 | $37.50 | 837.50% | Strong Buy | 2 | -9.98% | N/A | -44.33% | -14.62% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.53M | $1.07 | $10.00 | 834.58% | Strong Buy | 2 | N/A | N/A | -120.06% | -101.23% | |||
| LSTA | LISATA THERAPEUTICS INC | $22.87M | $2.66 | $23.50 | 783.46% | Strong Buy | 2 | 63.92% | N/A | -33.90% | -29.66% | |||
| IMUX | IMMUNIC INC | $76.46M | $0.80 | $7.00 | 777.19% | Strong Buy | 4 | N/A | N/A | -1,067.64% | 275.15% | |||
| JSPR | JASPER THERAPEUTICS INC | $38.36M | $2.36 | $20.14 | 753.52% | Buy | 7 | N/A | N/A | -217.81% | -110.16% | |||
| INTS | INTENSITY THERAPEUTICS INC | $12.56M | $0.27 | $2.25 | 742.70% | Strong Buy | 2 | N/A | N/A | -527.46% | -259.28% | |||
| PMN | PROMIS NEUROSCIENCES INC | $21.55M | $0.42 | $3.50 | 741.35% | Strong Buy | 2 | N/A | N/A | N/A | -398.95% | |||
| MBRX | MOLECULIN BIOTECH INC | $14.54M | $0.48 | $4.00 | 733.33% | Buy | 2 | N/A | N/A | N/A | -603.73% | |||
| VNRX | VOLITIONRX LTD | $46.27M | $0.43 | $3.50 | 713.95% | Strong Buy | 3 | 262.15% | N/A | -322.53% | 1,178.82% | |||
| MYO | MYOMO INC | $36.48M | $0.97 | $7.83 | 711.71% | Buy | 3 | 13.66% | N/A | 41.18% | 18.76% | |||
| ACET | ADICET BIO INC | $62.03M | $0.75 | $6.00 | 700.00% | Strong Buy | 2 | N/A | N/A | -24.95% | -21.06% | |||
| PASG | PASSAGE BIO INC | $23.62M | $7.43 | $59.25 | 697.44% | Strong Buy | 4 | N/A | N/A | -2.97% | -1.43% | |||
| BMEA | BIOMEA FUSION INC | $81.53M | $1.37 | $10.50 | 666.42% | Strong Buy | 6 | N/A | N/A | -277.27% | -104.26% | |||
| MTVA | METAVIA INC | $23.93M | $0.99 | $7.50 | 658.34% | Strong Buy | 2 | N/A | N/A | -1,174.59% | -612.40% | |||
| RNXT | RENOVORX INC | $38.48M | $1.05 | $7.50 | 614.29% | Buy | 2 | 283.58% | N/A | 94.84% | 73.97% | |||
| TIL | INSTIL BIO INC | $119.56M | $17.71 | $125.00 | 605.82% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $48.96M | $0.78 | $5.50 | 603.32% | Buy | 2 | 21.29% | N/A | N/A | N/A | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.82M | $9.38 | $65.00 | 593.33% | Buy | 2 | N/A | N/A | -67.83% | -58.29% | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $11.83M | $2.07 | $14.00 | 577.97% | Buy | 2 | N/A | N/A | -23.72% | -21.19% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $113.28M | $0.88 | $5.88 | 569.90% | Buy | 2 | N/A | N/A | -74.22% | -66.37% | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.77M | $5.25 | $34.75 | 561.90% | Strong Buy | 2 | 27.79% | N/A | -4.15% | -1.85% | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $270.69M | $1.22 | $8.00 | 555.74% | Strong Buy | 7 | N/A | N/A | -46.85% | -34.31% | |||
| ANVS | ANNOVIS BIO INC | $42.87M | $2.20 | $13.50 | 513.64% | Strong Buy | 2 | N/A | N/A | -166.98% | -142.67% | |||
| NEUP | NEUPHORIA THERAPEUTICS INC | $10.80M | $4.58 | $28.00 | 511.35% | Strong Buy | 2 | -100.00% | N/A | -59.15% | -39.32% | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $11.24M | $5.86 | $35.67 | 509.17% | Buy | 3 | 37.00% | N/A | -109.83% | -56.51% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.